======= PCGF6 =======
== Gene Information ==
* **Official Symbol**: PCGF6
* **Official Name**: polycomb group ring finger 6
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=84108|84108]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BYE7|Q9BYE7]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PCGF6&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PCGF6|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607816|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Transcriptional repressor (PubMed:12167161). May modulate the levels of histone H3K4Me3 by activating KDM5D histone demethylase (PubMed:17320162). Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:12167161). Within the PRC1-like complex, regulates RNF2 ubiquitin ligase activity (PubMed:26151332). {ECO:0000269|PubMed:12167161, ECO:0000269|PubMed:17320162, ECO:0000269|PubMed:26151332}.
|zf-C3HC4|
|inactivation of X chromosome by genetic imprinting|
|histone H2A-K119 monoubiquitination|
|PRC1 complex|
|dosage compensation by inactivation of X chromosome|
|regulation of gene expression by genetic imprinting|
|histone H2A monoubiquitination|
|dosage compensation|
|genetic imprinting|
|histone H2A ubiquitination|
|PcG protein complex|
|histone monoubiquitination|
|negative regulation of G0 to G1 transition|
|histone ubiquitination|
|regulation of G0 to G1 transition|
|protein monoubiquitination|
|regulation of gene expression, epigenetic|
|DNA-binding transcription repressor activity, RNA polymerase II-specific|
|RNA polymerase II regulatory region sequence-specific DNA binding|
|negative regulation of cell cycle process|
|histone modification|
|covalent chromatin modification|
|negative regulation of cell cycle|
|DNA-binding transcription factor activity|
|protein ubiquitination|
|chromatin organization|
|regulation of cell cycle process|
|protein modification by small protein conjugation|
|negative regulation of transcription by RNA polymerase II|
|protein modification by small protein conjugation or removal|
|chromosome organization|
|regulation of cell cycle|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp160|Ribavirin 10 to 15μM on day4 R04 exp160]]|-2.64|
|[[:results:exp360|Genistein 15μM R07 exp360]]|-1.71|
|[[:results:exp29|Rapamycin 1μM R00 exp29]]|1.7|
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|1.72|
|[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.96|
|[[:results:exp21|MLN-4924 0.2μM R00 exp21]]|2.02|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9335
* **Expression level (log2 read counts)**: 4.74
{{:chemogenomics:nalm6 dist.png?nolink |}}